{
  "disease_name": "Musculocontractural Ehlers-Danlos syndrome",
  "orpha_code": "2953",
  "drugs": [
    {
      "name": "Enzastaurin",
      "substance_url": "/en/drug/substance/76236?name=2953&mode=orpha&region=&status=all",
      "substance_id": "76236",
      "regulatory_url": "/en/drug/regulatory/627654?name=2953&mode=orpha&region=",
      "regulatory_id": "627654",
      "orpha_substance_code": "ORPHA:98249",
      "details": [
        "Enzastaurin(Medicinal product                        - 24/02/2022)Disease(s) concernedORPHA:98249 Ehlers-Danlos syndrome",
        "Enzastaurin(Medicinal product                        - 24/02/2022)",
        "(Medicinal product                        - 24/02/2022)",
        "Disease(s) concernedORPHA:98249 Ehlers-Danlos syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/76236?name=2953&mode=orpha&region=&status=all",
          "text": "Enzastaurin",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/98249",
          "text": "ORPHA:98249 Ehlers-Danlos syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/627654?name=2953&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Enzastaurin",
      "substance_url": "/en/drug/substance/76236?name=2953&mode=orpha&region=&status=all",
      "substance_id": "76236",
      "regulatory_url": "/en/drug/regulatory/682683?name=2953&mode=orpha&region=",
      "regulatory_id": "682683",
      "orpha_substance_code": "ORPHA:98249",
      "details": [
        "Enzastaurin(Medicinal product                        - 07/12/2021)Disease(s) concernedORPHA:98249 Ehlers-Danlos syndrome",
        "Enzastaurin(Medicinal product                        - 07/12/2021)",
        "(Medicinal product                        - 07/12/2021)",
        "Disease(s) concernedORPHA:98249 Ehlers-Danlos syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/76236?name=2953&mode=orpha&region=&status=all",
          "text": "Enzastaurin",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/98249",
          "text": "ORPHA:98249 Ehlers-Danlos syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/682683?name=2953&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T05:59:10.223886",
  "run_number": 1,
  "total_drugs_found": 2,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Musculocontractural+Ehlers-Danlos+syndrome&orphaCode=2953&name=2953&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Musculocontractural Ehlers-Danlos syndrome",
    "orphaCode": "2953",
    "name": "2953",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}